Livin upregulation in keratinocytes of psoriasis patients to promote adhesion molecule expression
暂无分享,去创建一个
[1] Miri Kim,et al. Angiogenesis in Chronic Inflammatory Skin Disorders , 2021, International journal of molecular sciences.
[2] Ho-Cheol Kang,et al. Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer. , 2021, Oncology reports.
[3] A. Trevani,et al. Protein A Modulates Neutrophil and Keratinocyte Signaling and Survival in Response to Staphylococcus aureus , 2021, Frontiers in Immunology.
[4] A. Waisman,et al. Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes. , 2019, The Journal of investigative dermatology.
[5] J. Gudjonsson,et al. Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk , 2019, Front. Immunol..
[6] Gang Wang,et al. Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] H. Katayama. Development of psoriasis by continuous neutrophil infiltration into the epidermis , 2018, Experimental dermatology.
[8] Chi-Yuan Chen,et al. Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte‐derived chemokine expression and neutrophil infiltration , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] X. Wang,et al. The inhibitor of apoptosis protein livin is upregulated in psoriasis vulgaris , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[10] K. Schäkel,et al. RNA-antimicrobial peptide complexes fuel a TLR- and NETosis-mediated inflammatory cycle of neutrophil activation in psoriasis , 2018, bioRxiv.
[11] G. Núñez,et al. Staphylococcus aureus Virulent PSMα Peptides Induce Keratinocyte Alarmin Release to Orchestrate IL-17-Dependent Skin Inflammation. , 2017, Cell host & microbe.
[12] Leping Li,et al. Livin serves as a prognostic marker for mid-distal rectal cancer and a target of mid-distal rectal cancer treatment , 2017, Oncology letters.
[13] M. Migliario,et al. Low concentrations of neutrophil extracellular traps induce proliferation in human keratinocytes via NF-kB activation. , 2017, Journal of dermatological science.
[14] T. Mayadas,et al. Lactoferrin Suppresses Neutrophil Extracellular Traps Release in Inflammation , 2016, EBioMedicine.
[15] N. Borregaard,et al. Neutrophil extracellular traps - the dark side of neutrophils. , 2016, The Journal of clinical investigation.
[16] A. Yang,et al. Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells. , 2016, Genetics and molecular research : GMR.
[17] Q. Lu,et al. The Inflammatory Response in Psoriasis: a Comprehensive Review , 2016, Clinical Reviews in Allergy & Immunology.
[18] Seamus J. Martin,et al. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines. , 2016, Cell reports.
[19] Y. Joo,et al. Livin is associated with the invasive and oncogenic phenotypes of human hepatocellular carcinoma cells , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[20] F. Bernard,et al. Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1α, TNFα and Oncostatin M , 2014, PloS one.
[21] C. Allis,et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation , 2009, The Journal of cell biology.
[22] Mei Han,et al. Challenge and promise: roles for Livin in progression and therapy of cancer , 2008, Molecular Cancer Therapeutics.
[23] Jongdae Lee,et al. IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition , 2002, Molecular and Cellular Biology.
[24] Xie-wan Chen,et al. Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer. , 2019, American journal of cancer research.